Literature DB >> 6293352

Survival in lung cancer. An analysis of the effects of age, sex, resectability, and histopathologic type.

T H Rossing, R G Rossing.   

Abstract

Records of 6,686 patients with primary lung malignancies were retrieved from a tumor registry. Survival curves according to histopathologic type demonstrated that patients with anaplastic tumors have a lower cumulative survival than those with either squamous cell cancers or adenocarcinomas (p less than 0.001), but survival for the latter two histologic types is similar. Age at diagnosis influences survival, and women with squamous or anaplastic tumors have a better prognosis than men with the same cell types (p less than 0.001). Although selection for resection is strongly associated with lower early mortality, all patients alive 2 yr after diagnosis have a similar prognosis is regardless of initial resectability. Each survival curve shows a high early mortality and a lower late mortality, indicating that each group can be considered to consist of 2 subgroups with different risks of dying of lung cancer. A mathematical model is described that closely approximates the actuarial survival.

Entities:  

Mesh:

Year:  1982        PMID: 6293352     DOI: 10.1164/arrd.1982.126.5.771

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Performance and prognosis in patients with lung cancer. The Edinburgh Lung Cancer Group.

Authors:  S Capewell; M F Sudlow
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

Review 2.  Management of lung cancer.

Authors:  M F Muers; R A Haward
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

3.  A monocyte function test (complement receptor enhancement) to assess the extent of bronchial carcinoma.

Authors:  M Carroll; M J Smith; M E Hodson; A B Kay
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

4.  Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.

Authors:  W Bakker; J M Nijhuis-Heddes; E A van der Velde
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Bronchioloalveolar carcinoma in African Americans.

Authors:  Syed Hasan; Humera Mujahid; Mahmoud Yousef; Reginald Chisholm
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

Review 6.  The aged patient with lung cancer. Management recommendations.

Authors:  V Zagonel; U Tirelli; D Serraino; G Lo Re; M C Merola; M Mascarin; M G Trovò; A Carbone; S Monfardini
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

Review 7.  Estrogen receptor pathways in lung cancer.

Authors:  Laura P Stabile; Jill M Siegfried
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.